Literature DB >> 3987204

Chronic active hepatitis and Behçet's syndrome.

R Manna, G Ghirlanda, G B Bochicchio, G Papa, V Annese, A V Greco, C A Taranto, M Magaro.   

Abstract

In a patient with Behcet's syndrome the finding of five times the normal level of serum transaminase accompanied by weakness may be correlated to the syndrome itself. We performed needle biopsy of the liver in our patient which showed piecemeal necrosis and portal lympho-monocytic infiltration extending into the lobule. It is interesting that HLA B5 and B27 antigens were present. Simultaneous occurrence of chronic active hepatitis and Behcet's syndrome may imply the same autoimmune pathogenesis, as we suggest in this work.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987204     DOI: 10.1007/bf02032326

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Clinical Studies on Behçet's Syndrome.

Authors:  Y Oshima; T Shimizu; R Yokohari; T Matsumoto; K Kano; T Kagami; H Nagaya
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

3.  [On a case of association of the Budd-Chiari syndrome and Behçet's syndrome].

Authors:  M Valleteau de Moulliac; D Morin; J Graveleau; R Perol; M Francoual; P Mornet
Journal:  Sem Hop       Date:  1974-10-26

4.  Behçet's syndrome with obstruction of the venae cavae. A report of seven cases.

Authors:  E Kansu; F L Ozer; E Akalin; Y Güler; T Zileli; E Tanman; E Kaplaman; E Müftüoğlu
Journal:  Q J Med       Date:  1972-04

5.  Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

Authors:  J Webb; K Whaley; R N MacSween; G Nuki; W C Dick; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

6.  Lymphocytotoxicity for oral epithelial cells in Behçet's disease: a case report.

Authors:  G Reimer; D Djawari
Journal:  Dermatologica       Date:  1982-02

7.  [Behçet's disease with renal manifestation. One case followed up for 6 years (author's transl)].

Authors:  M Hamza; H Ben Maiz; H Ben Ayed
Journal:  Sem Hop       Date:  1980 Jun 8-15

8.  The high prevalence of HLA-B5 in Behçet's disease.

Authors:  H Yazici; G Akokan; B Yalçin; A Müftüoğlu
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

9.  Behcet's syndrome in 32 patients in Yorkshire.

Authors:  M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

10.  Behcet's syndrome and renal involvement: a histological and immunofluorescent study of eleven renal biopsies.

Authors:  G Herreman; H Beaufils; P Godeau; B Cassou; B Wechsler; J Boujeau; G Chomette
Journal:  Am J Med Sci       Date:  1982 Jul-Aug       Impact factor: 2.378

View more
  5 in total

Review 1.  Adamantiades-Behcet's disease-complicated gastroenteropathy.

Authors:  Qing-Jun Wu; Feng-Chun Zhang; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 2.  Gastrointestinal manifestations of Behçet's disease.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

Review 3.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 4.  Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

Authors:  Anthony Nguyen; Shubhra Upadhyay; Muhammad Ali Javaid; Abdul Moiz Qureshi; Shahan Haseeb; Nismat Javed; Christopher Cormier; Asif Farooq; Abu Baker Sheikh
Journal:  Inflamm Intest Dis       Date:  2021-11-04

Review 5.  Autoimmune liver diseases in systemic rheumatic diseases.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.